Cargando…
Empirical versus preemptive antimycotic therapy in terms of outcome benefit
Autores principales: | Milanov, S, Todorova, VT, Georgiev, G, Milanov, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643104/ http://dx.doi.org/10.1186/cc12022 |
Ejemplares similares
-
Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
por: Todorova, VT, et al.
Publicado: (2013) -
Efficacy and utility of a protocol for pre-emptive antimycotic therapy
por: Milanov, SG, et al.
Publicado: (2010) -
Fungal infections in the intensive care unit? Another approach for defining a target group of patients who benefit from implementing preemptive antimycotic treatment
por: Geube, M, et al.
Publicado: (2007) -
Gram-positive nosocomial infections in a general ICU: emerging new clues
por: Milanov, S, et al.
Publicado: (2011) -
Gram-positive nosocomial infections in a general ICU: searching for a clue
por: Georgiev, G, et al.
Publicado: (2008)